CLINUVEL to cut up to 20% of staff and move headquarters to New York

CLINUVEL announced a strategic reorganization aimed at focusing resources on the U.S. market.

The company will reduce its global workforce by 10% to 20%, affecting up to 21 of its 104 employees.

It also plans to relocate its headquarters from Australia to New York at the start of 2027 to enhance regulatory engagement and commercial partnerships, especially for its late-stage vitiligo program targeting roughly 6 million U.S. patients.